Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30065189HIVENSG00000001084.13protein_codingGCLCNoNo2729E1CEI4
P48506
Q14TF0
TVIS20061305HPVENSG00000001084.13protein_codingGCLCNoNo2729E1CEI4
P48506
Q14TF0
TVIS20046313HPVENSG00000001084.13protein_codingGCLCNoNo2729E1CEI4
P48506
Q14TF0
TVIS20067763HPVENSG00000001084.13protein_codingGCLCNoNo2729E1CEI4
P48506
Q14TF0
TVIS44025744HTLV-1ENSG00000001084.13protein_codingGCLCNoNo2729E1CEI4
P48506
Q14TF0
TVIS44049006HTLV-1ENSG00000001084.13protein_codingGCLCNoNo2729E1CEI4
P48506
Q14TF0
TVIS44049007HTLV-1ENSG00000001084.13protein_codingGCLCNoNo2729E1CEI4
P48506
Q14TF0
TCGA Plot Options
Drug Information
GeneGCLC
DrugBank IDDB00142
Drug NameGlutamic acid
Target IDBE0000166
UniProt IDP48506
Regulation Typesubstrate
PubMed IDs22995213
CitationsLu SC: Glutathione synthesis. Biochim Biophys Acta. 2013 May;1830(5):3143-53. doi: 10.1016/j.bbagen.2012.09.008. Epub 2012 Sep 17.
GroupsApproved; Nutraceutical
Direct ClassificationGlutamic acid and derivatives
SMILESN[C@@H](CCC(O)=O)C(O)=O
PathwaysHistidinemia; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); 3-Methylglutaconic Aciduria Type I; beta-Ketothiolase Deficiency; Purine Nucleoside Phosphorylase Deficiency; Tyrosine Metabolism; Ketoprofen Action Pathway; Glutamate Metabolism; Argininosuccinic Aciduria; Salla Disease/Infantile Sialic Acid Storage Disease; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Celecoxib Action Pathway; Glycine and Serine Metabolism; Suprofen Action Pathway; Indomethacin Action Pathway; Carbamoyl Phosphate Synthetase Deficiency; Sialuria or French Type Sialuria; Ibuprofen Action Pathway; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Arginine and Proline Metabolism; Purine Metabolism; Diflunisal Action Pathway; Etodolac Action Pathway; Ammonia Recycling
PharmGKBPA449776
ChEMBLCHEMBL575060